高危HPV结合分型检测与宫颈癌生物学的相关性研究
2014-06-30黄光豪
黄光豪
摘要:目的:探讨高危HPV结合分型检测与宫颈癌生物的相关性。方法:选择2010年5月~2013年5月为我院收治的宫颈癌患者279例,采用HC II技术以及HybriMax技术检测HPV DNA病毒载量以及病毒分型,分析高危型HPV分型与宫颈癌生物学的相关性。结果:本组279例患者中,其中检出高危HPV DNA阳性患者258例,检出阳性率为92.47%;在HPV DNA基因型多重感染上,I-II期患者检出阳性率为13.27%、III-IV期患者检出阳性率为23.53%,二者比较,差异具有统计学意义(p<0.05);在HPV 18基因型上,鳞癌患者检出阳性率为6.8%、非鳞癌患者检出阳性率为18.75%,二者比较,差异具有统计学意义(p<0.05);在各HPV DNA基因型上,不同组织分化患者检出阳性率之间差异均不具有统计学意义(p>0.05)。结论::宫颈癌患者病情越严重其多重感染的检出率越高,且不同高危HPV分型与宫颈癌生物学行为具有着一定的相关性。
关键词:高危HPV;宫颈癌;相关性Abstract:Objective: To investigate the correlation of HPV with high risk genotypes and cervical cancer biology. Methods: in 2010 May ~2013 year in May 279 cases with cervical cancer patients, using the HC II technology and HybriMax technology in detection of HPV DNA viral load and virus types, analysis of the correlation between high-risk HPV subtypes and cervical cancer biology. Results: This group of 279 patients, including 258 cases of high-risk HPV detection of DNA positive patients, the positive rate was 92.47%; in the HPV genotype DNA infected patients with multiple, I-II positive rate was 13.27%, III-IV positive rate was 23.53% in patients, a comparison of the two, the difference was statistically significant (p<0.05); HPV genotype in 18 patients with squamous cell carcinoma, the positive rate was 6.8%, the positive rate in patients with non squamous cell carcinoma was 18.75% two, comparison, the difference was statistically significant (p<0.05); in the HPV genotype of DNA gene, the difference between different tissue differentiation in patients with positive rate were not statistically significant (p>0.05). Conclusion: the patients with cervical cancer disease severity of the multiple infection rate is higher, and different high risk type of HPV and the biological behavior of cervical cancer have a certain correlation.
Key words:High risk HPV; Cervical cancer; Correlation
【中圖分类号】R453【文献标识码】 A【文章编号】1002-3763(2014)09-0053-02宫颈癌是仅次于乳腺癌的全球第二常见的妇女癌症。现代研究已经公认了人乳头状瘤病毒(HPV)的感染是造成宫颈癌的一个主要病因[1]。由于高危型人乳头状瘤病毒的持续感染能够造成子宫癌前期病变以及宫颈癌的发生[2]。而HPV其具有着多种基因型,但是不同基因分型与宫颈癌生物学之间的相关性仍然未能获得研究者的共识。本研究探讨高危HPV结合分型检测与宫颈癌生物学行为之间的相关性,现报告如下:
1 资料与方法
1.1 临床资料
选择2010年5月~2013年5月为我院收治的宫颈癌患者279例,患者年龄在24~68岁之间,平均年龄为41.49岁,79例入组患者均经过病理学诊断确诊为宫颈癌。按照国际妇产科联盟标准临床分期[3],其中I期患者97例、II期患者114例、III期患者67例、IV期患者1例;按照WHO组织学类型标准[4],其中鳞癌患者247例、非鳞癌患者32例;……
